Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | TYR | P14679 | 2/20 | 0.40 |
| ▸ | LPL | P06858 | 6/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3785162 | 0.75 | LIPG (0.49) | LIPGCA1CA2TYRLPL | |
| SCHEMBL13429483 | 0.71 | TYR (0.40) | LIPGTYRMEN1TP53CYP3A4 | |
| SCHEMBL1677079 | 0.70 | GABRA1 (0.49) | LIPGCA1CA2TYRLPL | |
| SCHEMBL560421 | 0.70 | LIPG (0.66) | LIPGTYRLPLTRPV1MGLL | |
| SCHEMBL17746494 | 0.70 | ESR1 (0.34) | LIPGCA2LPLESR1ESR2 | |
| SCHEMBL17044883 | 0.70 | LIPG (0.66) | LIPGTYRLPLTRPV1MGLL | |
| SCHEMBL7031877 | 0.70 | LIPG (0.66) | LIPGTYRLPLTRPV1MGLL | |
| SCHEMBL1128560 | 0.70 | LIPG (0.85) | LIPGCA1CA2TYRLPL | |
| SCHEMBL29948801 | 0.70 | LIPG (0.85) | LIPGCA1CA2TYRLPL | |
| SCHEMBL3235115 | 0.69 | LIPG (0.50) | LIPGCA1CA2TYRLPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8153794-B2 | Catalysts useful for catalyzing the coupling of arylhalides with arylboronic acids | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-04-10 | — | — | US | disclosed |
| US-7524923-B1 | Suzuki polycondensation for preparing aryl polymers from dihalide monomers | DUPONT DISPLAYS, INC. (US) | 2009-04-28 | — | — | US | disclosed |
| US-20090054650-A1 | Novel Catalysts Useful for Catalyzing the Coupling of Arylhalides with Arylboronic Acids | IONKIN ALEX SERGEY | 2009-02-26 | — | — | US | disclosed |
| US-7449601-B2 | Catalysts useful for catalyzing the coupling of arylhalides with arylboronic acids | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-11-11 | — | — | US | disclosed |
| US-20060281923-A1 | Novel catalysts useful for catalyzing the coupling of arylhalides with arylboronic acids | E. I. DU PONT DE NEMOURS AND COMPANY | 2006-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054650-A1 | Novel Catalysts Useful for Catalyzing the Coupling of Arylhalides with Arylboronic Acids | DDT, AHR, DDC | LIPG 2597/4885CA1 3675/4885CA2 3224/4885 |
| US-20060281923-A1 | Novel catalysts useful for catalyzing the coupling of arylhalides with arylboronic acids | DDT, AHR, DDC | LIPG 2597/4885CA1 3675/4885CA2 3224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.